PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-10

Date Title Company
10-Feb-2026 GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older GSK
10-Feb-2026 Varicose Vein Treatment Market : Global Key Players, Trends, Share, Market Size, Segmentation, Opportunities, Forecast to 2030 Medi-Tech Insights
10-Feb-2026 TRNR Files Lawsuits Against Sportstech and Ali Ahmad and Announces March 11, 2026 Public Auction of All Shares of Sportstech ACCESS Newswire
10-Feb-2026 MDCE Turns $1M Asset Portfolio Into Strategic Capital for AI Development (OTC PINK:MDCE) ACCESS Newswire
10-Feb-2026 Change of Date for Publication of the Interim Report January-March 2026 ACCESS Newswire
10-Feb-2026 NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement ACCESS Newswire
10-Feb-2026 LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE Lumosa Therapeutics
10-Feb-2026 4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthritis Businesswire
10-Feb-2026 Pandemics, obesity drugs and cancer care: Cambridge experts tackle the health issues shaping the UK Cambridge Festival
10-Feb-2026 Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides ACCESS Newswire
10-Feb-2026 IGC Pharma Announces Equity Research Update by Alliance Global Partners ACCESS Newswire
10-Feb-2026 Microbiology Culture Market Strategic Insights and Growth Opportunities with Key Players and Forecast to 2031 Medi-Tech Insights
10-Feb-2026 OPEN Health today announced senior leadership appointments that reinforce the company’s commitment to disciplined growth, enterprise alignment, and the company’s purpose of strengthening the decisions that shape care. OPEN Health
10-Feb-2026 Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies Kainova Therapeutics
10-Feb-2026 Calbiotech and Liquid Biosciences Announce Strategic Collaboration to Accelerate Next-Generation Diagnostic Development ACCESS Newswire
10-Feb-2026 Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement ACCESS Newswire
10-Feb-2026 VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics
10-Feb-2026 The PM Society Launches Pharmony to Support More Effective Pharma-Agency Collaboration The PM Society
10-Feb-2026 Longwood Healthcare Leaders to Host Senior Pharma and Biotech Leaders at Annual Leadership Summit, Miami CEO ACCESS Newswire
10-Feb-2026 Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico ACCESS Newswire